Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy

Documenti analoghi

• Epigenetic drug Gar1041 in combination with antiretroviral therapy transiently reduces the proviral DNA reservoir in SIVmac251-infected macaques
  di: Lewis, MG, et al.
  Pubblicazione: (2010)
• A Highly Intensified ART Regimen Induces Long-Term Viral Suppression and Restriction of the Viral Reservoir in a Simian AIDS Model
  di: Shytaj, Iart Luca, et al.
  Pubblicazione: (2012)
• Lentiviral Vector-Based Prime/Boost Vaccination against AIDS: Pilot Study Shows Protection against Simian Immunodeficiency Virus SIVmac251 Challenge in Macaques
  di: Beignon, Anne-Sophie, et al.
  Pubblicazione: (2009)
• Comparison of the transcriptional activity of the long terminal repeats of simian immunodeficiency viruses SIVmac251 and SIVmac239 in T-cell lines and macrophage cell lines.
  di: Anderson, M G, et al.
  Pubblicazione: (1991)
• DNA Vaccines Expressing Different Forms of Simian Immunodeficiency Virus Antigens Decrease Viremia upon SIVmac251 Challenge
  di: Rosati, Margherita, et al.
  Pubblicazione: (2005)